Mechanisms Modulating Cytoskeletal Dynamics During Schwann Cell Myelination
雪旺细胞髓鞘形成过程中细胞骨架动力学的调节机制
基本信息
- 批准号:7737261
- 负责人:
- 金额:$ 40.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-20 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAction PotentialsAcuteAffectAfferent NeuronsAxonBasal laminaCell membraneCellsCellular MorphologyCoculture TechniquesCuesCyclic AMP-Dependent Protein KinasesCytoskeletonDataDemyelinating DiseasesDevelopmentDiseaseDrug Delivery SystemsEatingElectronsExtracellular MatrixF-ActinFoundationsGenesGoalsImageIn VitroIntegrinsLIM Domain Kinase 1LamininLifeLigandsLightLinkMapsMeasuresMediatingMediator of activation proteinMicroscopicModelingMolecularMorphologyMyelinMyelin SheathNerveNervous system structureNeuregulinsNeurofibromatosesNeurofibromatosis 2Neurofibromin 2NeurogliaOutcomePathologyPathway interactionsPeptidesPeripheral Nervous SystemPhosphorylationPhosphotransferasesPositioning AttributeProcessProteinsPublishingRanvier&aposs NodesRattusReportingResearchResearch PersonnelRoleSchwann CellsSchwannomatosisSensorySignal PathwaySignal TransductionStagingTestingTimeTumor Suppressor ProteinsWorkcofilincombinatorialin vivokinase inhibitorknock-downlentiviral-mediatedmyelinationneurological pathologynovelp21 activated kinasepaxillinpolymerizationpreventpublic health relevancereceptorresearch studyresponserho GTP-Binding Proteinstumoryoung adult
项目摘要
Myelination allows rapid propagation of action potentials in the nervous system. Dys- and demyelinating disorders are among the most common neurological pathologies affecting young adults. Myelinating glial cells such as Schwann cells of the peripheral nervous system undergo stage specific changes in morphology that enable them to elaborate myelin around an axon. The signaling pathways that regulate actin dynamics in response to extrinsic axonal and extracellular matrix cues are largely unknown. We recently reported that activation of ErbB and B1 integrin receptors induces phosphorylation of Schwannomin, the Neurofibromatosis type 2 tumor suppressor. Schwannomin links receptors to the actin cytoskeleton and modulates the activity of Cdc42/RacGTPase. Thus it is positioned to link receptor activity to actin dynamics and trigger changes in cellular morphology needed for myelination. We hypothesize that Sch modulates actin polymerization through a p21activated kinase (PAK) - LIM kinase - cofilin pathway. In Aim 1, we propose to elucidate the function of cofilin during Schwann cell myelination. We will compare the ability normal and cofilin-deficient Schwann cells to myelinate axons in vitro. In Aim 2, we will assess whether neuregulin and laminin regulate LlMK and cofilin phosphorylation. We will determine whether cofilin is needed for Schwann cells to remodel their plasma membrane in response to NRG and laminin stimulation by conducting live imaging experiments with normal and cofilin-deficient Schwann cells. The immediate outcome of this work will be to identify a novel pathway used by Schwann cells to produce receptor specific changes in morphology associated with myelination. If successful, this work will provide the first complete map of a signaling cascade initiated by axonal and basal lamina ligands that terminates at the final downstream effector protein, actin. This information will impact the identification of increasingly specific drug targets for development of single and combinatorial therapies for myelinating disorders and other Schwann cell disorders such as Neurofibromatosis and Schwannomatosis.
髓鞘形成允许神经系统中动作电位的快速传播。髓鞘发育不良和脱髓鞘疾病是影响年轻人的最常见的神经病理学疾病之一。周围神经系统的髓鞘神经胶质细胞(例如雪旺细胞)经历特定阶段的形态变化,使它们能够在轴突周围形成髓磷脂。响应外在轴突和细胞外基质信号而调节肌动蛋白动力学的信号通路在很大程度上是未知的。我们最近报道,ErbB 和 B1 整合素受体的激活会诱导 2 型神经纤维瘤病肿瘤抑制因子 Schwannomin 的磷酸化。 Schwannomin 将受体与肌动蛋白细胞骨架连接起来并调节 Cdc42/RacGTPase 的活性。因此,它的定位是将受体活性与肌动蛋白动力学联系起来,并触发髓鞘形成所需的细胞形态的变化。我们假设 Sch 通过 p21 激活激酶 (PAK) - LIM 激酶 - cofilin 途径调节肌动蛋白聚合。在目标 1 中,我们建议阐明丝切蛋白在雪旺细胞髓鞘形成过程中的功能。我们将比较正常和丝切蛋白缺陷的雪旺细胞在体外使轴突髓鞘化的能力。在目标 2 中,我们将评估神经调节蛋白和层粘连蛋白是否调节 LlMK 和丝切蛋白磷酸化。我们将通过对正常和肌动蛋白丝切蛋白缺陷的施万细胞进行活体成像实验,确定施万细胞是否需要肌动蛋白丝切蛋白来重塑其质膜以响应NRG和层粘连蛋白的刺激。这项工作的直接成果将是确定雪旺细胞使用的一种新途径,以产生与髓鞘形成相关的受体特异性形态变化。如果成功,这项工作将提供由轴突和基底层配体启动的信号级联的第一个完整图谱,该级联在最终下游效应蛋白肌动蛋白处终止。这些信息将影响越来越具体的药物靶标的确定,以开发针对髓鞘疾病和其他施万细胞疾病(例如神经纤维瘤病和神经鞘瘤病)的单一和组合疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRISTINA Maria FERNANDEZ-VALLE其他文献
CRISTINA Maria FERNANDEZ-VALLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRISTINA Maria FERNANDEZ-VALLE', 18)}}的其他基金
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
PI3K 抑制剂治疗前庭神经鞘瘤的临床前测试
- 批准号:
10447797 - 财政年份:2018
- 资助金额:
$ 40.36万 - 项目类别:
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
PI3K 抑制剂治疗前庭神经鞘瘤的临床前测试
- 批准号:
10238743 - 财政年份:2018
- 资助金额:
$ 40.36万 - 项目类别:
ZEISS Spinning Disc/LSM700 Point Scanning Confocal Microscope with Incubation Sys
蔡司转盘/LSM700 点扫描共焦显微镜,带孵化系统
- 批准号:
7794517 - 财政年份:2010
- 资助金额:
$ 40.36万 - 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
- 批准号:
8278031 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
- 批准号:
8082728 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
- 批准号:
7878605 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
- 批准号:
7699548 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2
鉴定用于预防 NF2 引起的耳聋的新药物靶点
- 批准号:
8495967 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
相似国自然基金
神经系统中动作电位双稳传导研究
- 批准号:12375033
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
与痛觉相关的动作电位传导失败的动力学与调控机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
仿生味觉自适应柔性纳米电极阵列构建研究
- 批准号:61901469
- 批准年份:2019
- 资助金额:24.5 万元
- 项目类别:青年科学基金项目
晚钠电流通过CaMK-II调节跨壁胞内钙离子分布在心肌缺血再灌注心律失常中的作用及机制研究
- 批准号:81900300
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
神经元离子通道-动作电位-量子化分泌关系研究
- 批准号:31930061
- 批准年份:2019
- 资助金额:303 万元
- 项目类别:重点项目
相似海外基金
Connexin-based Signaling in the Heart: Cellular and Exosomal
心脏中基于连接蛋白的信号传导:细胞和外泌体
- 批准号:
10553255 - 财政年份:2022
- 资助金额:
$ 40.36万 - 项目类别:
Connexin-based Signaling in the Heart: Cellular and Exosomal
心脏中基于连接蛋白的信号传导:细胞和外泌体
- 批准号:
10353582 - 财政年份:2022
- 资助金额:
$ 40.36万 - 项目类别:
Multiparametric Biosensor Imaging in Brain Slices
脑切片多参数生物传感器成像
- 批准号:
9449901 - 财政年份:2016
- 资助金额:
$ 40.36万 - 项目类别:
Multiparametric Biosensor Imaging in Brain Slices
脑切片多参数生物传感器成像
- 批准号:
9214054 - 财政年份:2016
- 资助金额:
$ 40.36万 - 项目类别:
Using Mechanical Loading to Develop Human iPSC-Derived Models of Cardiomyopathy
使用机械负载开发人类 iPSC 衍生的心肌病模型
- 批准号:
8909611 - 财政年份:2015
- 资助金额:
$ 40.36万 - 项目类别: